期刊文献+

幽门螺杆菌VacA-HpaA融合蛋白的表达及其免疫学特性

Expression and Immunological Characteristic of VacA-HpaA Fusion Protein of Helicobacter pylori
下载PDF
导出
摘要 目的构建H.pylori细胞空泡毒素VacA与黏附素HpaA融合基因的原核表达载体,诱导其表达融合蛋白,并检测表达产物的抗原性与免疫原性。方法用PCR从pQE30-VacA质粒扩增出VacA基因,克隆至pTrc99A-HpaA载体中,与HpaA基因融合后,插入原核表达载体pQE30中,再将pQE30-VacA-HpaA转化入大肠杆菌DH5α,诱导表达并提纯融合蛋白,SDS-PAGE检测融合蛋白的表达,Bradford法检测融合蛋白含量,Western blot鉴定特异性。将融合蛋白免疫家兔,得到多克隆抗血清,用双向免疫扩散和ELISA检测免疫原性。结果SDS-PAGE显示融合蛋白相对分子质量约为65000,表达量在35%以上,主要以包涵体形式表达,蛋白含量为0·72mg/ml,具有良好的VacA和HpaA抗原性与免疫原性。结论VacA-HpaA融合蛋白已成功表达,且具有良好的免疫原性,为进一步研究制备H.pylori疫苗创造了条件。 Objective To construct the prokaryotic expression vector for fusion gene of VacA and HpaA of Helicobacter pylori, induce the expression of VacA-HpaA fusion protein and study the antigenicity and immunogenicity of expressed product. Methods Amplify VacA gene from pQE30-VacA plasmid and fuse with the HpaA gerre in vector pTrc99A-HpaA. Insert the fusion gene into prokaryotic expression vector pQE30,then transform the constructed recombinant plasmid pQE30-VacA-HpaA to E. coli DH5α for expression of VacA-HpaA fusion protein. Purify the expressed product by Ni^2+ -NTA affinity chromatography and identify by SDS-PAGE. Analyze the content of fusion protein by Bradford method and the specificity by Western blot. Immunize rabbits with the fusion protein to prepare polyclonal antiserum and determine for immunogenicity by double immunodiffusion test and ELISA. Results SDS-PAGE showed that the fusion protein with a relative molecular weight of about 65 000 was expressed in a form of inclusion body and contained more than 30% of total somatic protein. The expressed product ,at a protein content of 0.72 mg/ml ,showed good antigenicity and immu- nogenicity of both VacA and HpaA. Conclusion VacA-HpaA fusion protein was successfully expressed. It laid a foundation of further development of H. pylori vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第5期450-453,共4页 Chinese Journal of Biologicals
基金 重庆市教委科学基金资助(渝教科2003-7-3)
关键词 幽门螺杆菌 细胞空泡毒素 黏附素 融合蛋白 Helicobacter pyloro Vacuolating cytotoxin antigen (VacA) Adhesin Fusion protein
  • 相关文献

参考文献7

  • 1Blaser MJ.Hypothesis:the changing relationship of Helicobacter pylori and human:implication for health and disease.J Infect Dis,1999,179(6):1523-1530.
  • 2Voland P,Hafsi N,Zeitner M,et al.Antigenic properties of HpaA and Omp18,two outer membrane proteins of Helicobacter pylori.Infect Immun,2003,71 (7):3837-3843.
  • 3Lundstrom AM,Bolin I,Bystrom M,et al.Recombinant hpaA purified from Escherichia coil has biological properties similar to those of native Helicobacter pylori HpaA.APMIS,2003,111 (3):389-397.
  • 4Chen M,Lee A,Hazeli SL.Immunization against gastric helicobacter infection in a mouse Helicobacter feli mode.Lancet,1992,339(8):1112-1120.
  • 5罗治彬,徐采朴.幽门螺杆菌工程疫苗研究进展[J].世界华人消化杂志,2000,8(4):449-451. 被引量:5
  • 6Penicher ML,Morrison SL.Antibody-cytokine fusion proteins for therapy of cancer.J Immunol Methods,2001,248 (1-2):91-101.
  • 7Reiter Y.Recombinant immunotoxins in targeted cancer cell therapy.Adv Cancer Res,2001,81 (6):93-124.

二级参考文献22

  • 1[1]McLaughlin P. Teatment of foliicular and other indolent lymphomas.Curr Opin Oncol,1999;11:333-338
  • 2[3]Lazowska I,Trzeciak L,Godlewska R,Hennig E,Jagusztyn-Krynicka K,Popowski J,Regula J,Ostrowski J,In search of immunogenic Helicobacter pylori proteins by screening of expression library.Digestion,2000;61:14-21
  • 3[4]Kimmel B,Bosserhoff A,Frank R,Gross R,Goebel W,Beier D,Identification of immunodominant antigens form Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies,Infect Immun.2000;68:915-920
  • 4[5]Rupnow MF,Owens DK,Shachter R,Parsonnet J.Helicobacter pylori vaccine development and use:a cost-effectiveness analysis using the Instiute of Medicine Methodology,Helicobacter,1999;4:272-280
  • 5[6]Dieterick C.Bouzourene H,Blum AL,Corthesy-Theulaz IE.Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice.Infect Immun,1999;67:6206-6209
  • 6[7]Ernst JD.Toward the development of antibacterial vaccines:report of a symposium and workshop.Organizing Committee.Clin Infect Dis,1999;29:1295-1302
  • 7[8]Blanchard TG,Czinn SJ,Nedrud JG,Killeen KP,Hohmann EL.Host response and vaccine development to Helicobacter pylori infection.Curr Top Microbiol Immunol,1999;241:181-213
  • 8[9]Ghiara P,Rossi M,Marchetti M,Guidi L,Frasca D,Costanzo M.Therapeutic intragastric vaccination against Helicobacter Pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.Infect Immune,1997;65:4996-5002
  • 9[10]Marchetti M,Rossi M,Giannelli V,Tricerri A,Guidi L.Protection against Helicobacter pylori infection in mice by intragastric vaccination with Helicobacter pylori antiens is achieved using a non-toxic mutant of E-coli heat-labile enterotoxin(LT)asadjuvant.Vaccine,1998;16:33-37
  • 10[12]Michetti P,Kreiss C,Kotloff K, Cahill R, Simmons C, Dougan G. Oral immunization of H,pylori infected adults with recombinant urease and LT adjuvant[abstract],Gastroenterology,1997;112:A1042

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部